The BIO International Convention, taking place June 3-6, 2024, is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with more than 18,500 industry leaders from across the globe.

EffRx proactively seeks in-licensing opportunities for Europe in niche therapeutic areas, primarily interested in rare diseases, endocrinology, and musculoskeletal diseases, and will meet with prospective companies to discuss possible collaborations.